Fundraising

Aliada Therapeutics

Aliada Therapeutics Raises $1.4B in Acquisition

2018
Founded
90+
Employees
South San Francisco, CA
2 min read

Quick Facts

Aliada Therapeutics Raises $1.4B in Acquisition


Aliada Therapeutics has successfully raised $1.4B in a Acquisition at a $1.4B valuation led by AbbVie (acquirer).


Company Overview


Aliada Therapeutics is a Biotech company headquartered in South San Francisco, CA, founded in 2018 with 90+ employees.


Blood-brain barrier platform acquired by AbbVie for CNS therapies


Fundraising Details


  • Amount Raised: $1.4B
  • Round Type: Acquisition
  • Valuation: $1.4B
  • Date: 2024-10-25
  • Investors: AbbVie (acquirer)

About Aliada Therapeutics


Blood-brain barrier platform acquired by AbbVie for CNS therapies The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: South San Francisco, CA
  • Founded: 2018
  • Team Size: 90+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Aliada Therapeutics's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Aliada Therapeutics's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1.4B valuation marks an important milestone for Aliada Therapeutics, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Aliada Therapeutics is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-10-25. For more information about Aliada Therapeutics, visit their headquarters at South San Francisco, CA.

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news